Company · CIK 0001437786
IMMUNE DESIGN CORP.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-19-095238 · 94.7 KBSEC(opens sec.gov)
- 10-K/AIMMUNE DESIGN CORP.0001437786-19-000009 · 551.4 KBSEC(opens sec.gov)
- 10-KAnnual report0001437786-19-000006 · 7.3 MBSEC(opens sec.gov)
- SC 13G/AIMMUNE DESIGN CORP.0000935836-19-000163 · 47.0 KBSEC(opens sec.gov)
- SC 13D/AIMMUNE DESIGN CORP.0001104659-19-011587 · 398.0 KBSEC(opens sec.gov)
- SC 13G/AIMMUNE DESIGN CORP.0000921895-19-000572 · 201.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-19-046201 · 534.8 KBSEC(opens sec.gov)
- SC 13D/AIMMUNE DESIGN CORP.0001193125-19-044282 · 184.2 KBSEC(opens sec.gov)
- SC 13G/AIMMUNE DESIGN CORP.0000921895-19-000472 · 209.9 KBSEC(opens sec.gov)
- SC 13G/AIMMUNE DESIGN CORP.0001104659-19-008423 · 150.7 KBSEC(opens sec.gov)
Insiders
- Alta Partners VIII, L.P.10% Owner
- ATWOOD BRIAN GDirector
- BALTIMORE DAVIDDirector
- BERGER FRANKLIN MDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Brady Stephen REVP, Strategy & Finance
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
Tickers
No tickers on record.
Addresses
business
1616 EASTLAKE AVENUE E. SUITE 310
SEATTLE, WA, 98102
mailing
601 GATEWAY BOULEVARD SUITE 250
SOUTH SAN FRANCISCO, CA, 94080
Former names
- VACCSYS INC2008-06-13
Same industry